Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy.

Volume: 1, Issue: 1, Pages: 16037
Published: Oct 19, 2016
Abstract
Metastatic basal cell carcinomas are rare malignancies harbouring Hedgehog pathway alterations targetable by SMO antagonists (vismodegib/sonidegib). We describe, for the first time, the molecular genetics and response of a patient with Hedgehog inhibitor-resistant metastatic basal cell carcinoma who achieved rapid tumour regression (ongoing near complete remission at 4 months) with nivolumab (anti-PD1 antibody). He had multiple hallmarks of...
Paper Details
Title
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy.
Published Date
Oct 19, 2016
Volume
1
Issue
1
Pages
16037
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.